Latest filing published 26 Feb 2019 for Aimmune Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Mary M. Rozenman: trading record in brief
Mary M. Rozenman appears in our data through filings on Aimmune Therapeutics, Inc. shares, published by SEC (Form 4). We count 44 filings; the first trade dates from 8 September 2016 and the latest from 22 February 2019.
On the market, this insider has only sold: 28 sales, €5.8M in total. Outside the open market, there are 2 share grants and 13 option exercises.
The record was last updated on 26 February 2019 with a share grant in Aimmune Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mary M. Rozenman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares0Common Stock, $0.0001 par valueSEC:0000899243-19-004862:0
- 6,875 shares0Common Stock, $0.0001 par valueSEC:0000899243-18-006566:0
- 1,807 shares@ US$3.020.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-006330:0
- 1,807 shares@ US$33.100.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-006330:1
- 6,592 shares@ US$3.020.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-002882:0
- 2,300 shares@ US$34.951.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-002882:1
- 4,292 shares@ US$35.582.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-002882:2
- 6,591 shares@ US$3.020.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000456:0
- 4,990 shares@ US$37.122.6% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000456:1
- 1,601 shares@ US$37.080.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000456:2
- 75,010 shares@ US$3.023.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:0
- 11,000 shares@ US$38.836.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:1
- 1,500 shares@ US$39.250.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:2
- 10,700 shares@ US$38.825.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:3
- 1,800 shares@ US$39.231.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:4
- 11,000 shares@ US$38.826.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:7
- 1,500 shares@ US$39.230.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:8
- 4,310 shares@ US$38.802.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:9
- 700 shares@ US$39.260.4% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:10
- 8,800 shares@ US$38.834.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:11
- 1,200 shares@ US$39.280.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:12
- 6,400 shares@ US$38.733.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:13
- 3,600 shares@ US$39.152.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-029679:14
- 30,000 shares@ US$3.021.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-021814:0
- 30,000 shares@ US$22.509.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-021814:1
25 of 42 declarations
